Summary
- Amwell seeks to raise $525 million in an IPO of its Class A stock.
- The firm provides a telehealth delivery system to healthcare providers in the U.S.
- AMWL has grown rapidly due to the Covid-19 pandemic's effects on healthcare providers offering remote patient services and the industry is slated for future growth.
- The IPO appears comparatively reasonably priced, so is worth consideration.
- Looking for more investing ideas like this one? Get them exclusively at IPO Edge. Get started today ยป
Quick Take
American Well Corporation (AMWL) has filed to raise $525 million in an IPO of its Class A common stock, according to an S-1 registration statement.
Amwell provides a telehealth services delivery platform for healthcare service providers in the United States.
AMWL is growing rapidly and will have industry tailwinds in its favor in the coming years, so the IPO is worth a close look.
Company & Technology
Boston, Massachusetts-based Amwell was founded to develop the Amwell Platform, a telehealth system that enables a wide variety of healthcare services to be delivered remotely.
Management is headed by Chairman and Co-CEO Ido Schoenberg, MD and president and Co-CEO Roy Schoenberg, MD, MPH.
Ido was previously co-founder of iMDSoft and Roy was previously the founder of CareKey, an electronic health management software vendor.
Below is a brief overview video of the firm's approach:
